Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer

CONCLUSIONS: The expression of FGF19 is significantly upregulated in NSCLC, and the overexpression of FGF19 is correlated with poor OS, especially in lung adenocarcinoma (LUAD) cases. FGF19 might serve as a potential biomarker for predicting poor OS in NSCLC patients.PMID:33841967 | PMC:PMC8024864 | DOI:10.21037/jtd-21-126

Source: Journal of Thoracic Disease - April 12, 2021 Category: Respiratory Medicine Authors: Jia Chen Jingjing Shao Aiguo Shen Xinghua Zhu Xunlei Zhang Hui Sun Sheng Wei Yang Ling Source Type: research